ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 福島医学会
  2. Fukushima Journal of Medical Science
  3. Vol.61 (2015)

Validation of therapeutic response assessment by bone scintigraphy in patients with bone-only metastatic breast cancers during zoledronic acid treatment: comparison with computed tomography assessment

https://fmu.repo.nii.ac.jp/records/2001890
https://fmu.repo.nii.ac.jp/records/2001890
6c9f314f-b209-4898-9487-c120b94ebafd
名前 / ファイル ライセンス アクション
FksmJMedSci_61_p23.pdf FksmJMedSci_61_p23.pdf (673.4 KB)
Item type デフォルトアイテムタイプ(フル)fmu(1)
公開日 2015-08-05
タイトル
タイトル Validation of therapeutic response assessment by bone scintigraphy in patients with bone-only metastatic breast cancers during zoledronic acid treatment: comparison with computed tomography assessment
言語 en
作成者 Ishii, Shirou

× Ishii, Shirou

en Ishii, Shirou

Search repository
Kikuchi, Ken

× Kikuchi, Ken

en Kikuchi, Ken

Search repository
Miyajima, Masayuki

× Miyajima, Masayuki

en Miyajima, Masayuki

Search repository
Sakuma, Kotaro

× Sakuma, Kotaro

en Sakuma, Kotaro

Search repository
Shishido, Fumio

× Shishido, Fumio

en Shishido, Fumio

Search repository
権利情報
権利情報 © 2015 The Fukushima Society of Medical Science
内容記述
内容記述タイプ Abstract
内容記述 Purpose: To validate the use of bone scintigraphy (BS) versus computed tomography (CT) for therapeutic monitoring in patients during treatment with zoledronic acid. Materials and Methods: Eleven patients with bone-only metastatic disease and being treated with zoledronic acid were included. The effects of therapies including chemotherapy and hormone therapy were evaluated in 25 separate examinations in total as follows: complete response (CR), when no bone metastasis was visible; partial response (PR), when a decrease in the lesion area was detected; stable disease (SD), when no or slight change was observed; and progressive disease (PD), when new or enlarged lesion areas were observed. Results: The accuracies of examination by Readers 1, 2, and 3 respectively were 76%, 80% and 76% for BS, 52%, 48%, and 40% for CT, and 64%, 52% and 60% for BS and CT combined with Readers 2 and 3 observing significant differences between CT and BS results. The rates of interobserver agreement between Readers 1 and 2, between Readers 1 and 3, and between Reader 2 and 3 respectively, were 84%, 80% and 88% (κ = 0.648, 0.561 and 0.766) for BS, 52%, 56%, and 60% (κ = 0.180, 0.278 and 0.282) for CT, and 52%, 60%, and 56% (κ = 0.215, 0.282 and 0.232) for CT and BS combined. Conclusion: BS is effective for assessing the response of bone metastasis to therapy in patients during zoledronic acid treatment.
出版者
出版者 The Fukushima Society of Medical Science
言語
言語 eng
書誌情報 en : Fukushima Journal of Medical Science

巻 61, 号 1, p. 23-31, 発行日 2015
関連情報
関連タイプ isIdenticalTo
識別子タイプ DOI
関連識別子 https://doi.org/10.5387/fms.2013-15
関連情報
識別子タイプ PMID
関連識別子 25946906
関連情報
識別子タイプ ICHUSHI
関連識別子 2016216416
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
資源タイプ journal article
出版タイプ
出版タイプ VoR
出版タイプResource http://purl.org/coar/version/c_970fb48d4fbd8a85
収録物識別子
収録物識別子タイプ PISSN
収録物識別子 0016-2590
収録物識別子
収録物識別子タイプ EISSN
収録物識別子 2185-4610
収録物識別子
収録物識別子タイプ NCID
収録物識別子 AA0065246X
主題
主題Scheme Other
主題 bone scintigraphy
主題
主題Scheme Other
主題 computed tomography
主題
主題Scheme Other
主題 tumor marker
主題
主題Scheme Other
主題 bone metastases
主題
主題Scheme Other
主題 therapeutic monitoring
戻る
0
views
See details
Views

Versions

Ver.1 2024-12-02 02:07:04.424734
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3